Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults ≥ 55 Years Old. A Study Protocol for a Double-Blinded Randomized Controlled Clinical Trial

被引:5
作者
Avgerinos, K., I [1 ]
Mullins, R. J. [1 ]
Egan, J. M. [1 ]
Kapogiannis, D. [1 ]
机构
[1] NIA, NIH, Lab Clin Invest, 251 Bayview Blvd,8C228, Baltimore, MD 21224 USA
来源
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE | 2022年 / 9卷 / 01期
关键词
Ketosis; ketone ester; metabolic syndrome; Alzheimer's disease; magnetic resonance spectroscopy; cognition; extracellular vesicles; ALZHEIMERS-DISEASE; MOUSE MODEL; GLUCOSE-METABOLISM; SPECTROSCOPY; EXOSOMES; MILD; ABNORMALITIES; PROTEINS; CHILDREN; EFFICACY;
D O I
10.14283/jpad.2022.3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Ketone bodies have been proposed as an "energy rescue" for the Alzheimer's disease (AD) brain, which underutilizes glucose. Prior research has shown that oral ketone monoester (KME) safely induces robust ketosis in humans and has demonstrated cognitive-enhancing and pathology-reducing properties in animal models of AD. However, human evidence that KME may enhance brain ketone metabolism, improve cognitive performance and engage AD pathogenic cascades is scarce. Objectives To investigate the effects of ketone monoester (KME) on brain metabolism, cognitive performance and AD pathogenic cascades in cognitively normal older adults with metabolic syndrome and therefore at higher risk for AD. DESIGN: Double-blinded randomized placebo-controlled clinical trial. Setting Clinical Unit of the National Institute on Aging, Baltimore, US. Participants Fifty cognitively intact adults >= 55 years old, with metabolic syndrome. Intervention Drinks containing 25 g of KME or isocaloric placebo consumed three times daily for 28 days. Outcomes Primary: concentration of beta-hydroxybutyrate (BHB) in precuneus measured with Magnetic Resonance Spectroscopy (MRS). Exploratory: plasma and urine BHB, multiple brain and muscle metabolites detected with MRS, cognition assessed with the PACC and NIH toolbox, biomarkers of AD and metabolic mediators in plasma extracellular vesicles, and stool microbiome. Discussion This is the first study to investigate the AD-biomarker and cognitive effects of KME in humans. Ketone monoester is safe, tolerable, induces robust ketosis, and animal studies indicate that it can modify AD pathology. By conducting a study of KME in a population at risk for AD, we hope to bridge the existing gap between pre-clinical evidence and the potential for brain-metabolic, pro-cognitive, and anti-Alzheimer's effects in humans.
引用
收藏
页码:54 / 66
页数:13
相关论文
共 77 条
  • [51] Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease
    Mustapic, Maja
    Tran, Joyce
    Craft, Suzanne
    Kapogiannis, Dimitrios
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (02) : 489 - 498
  • [52] Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes
    Mustapic, Maja
    Eitan, Erez
    Werner, John K., Jr.
    Berkowitz, Sean T.
    Lazaropoulos, Michael P.
    Tran, Joyce
    Goetzl, Edward J.
    Kapogiannis, Dimitrios
    [J]. FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [53] Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study
    Neth, Bryan J.
    Mintz, Akiva
    Whitlow, Christopher
    Jung, Youngkyoo
    Sai, Kiran Solingapuram
    Register, Thomas C.
    Kellar, Derek
    Lockhart, Samuel N.
    Hoscheidt, Siobhan
    Maldjian, Joseph
    Heslegrave, Amanda J.
    Blennow, Kaj
    Cunnane, Stephen C.
    Castellano, Christian-Alexandre
    Zetterberg, Henrik
    Craft, Suzanne
    [J]. NEUROBIOLOGY OF AGING, 2020, 86 : 54 - 63
  • [54] Ketone production by ketogenic diet and by intermittent fasting has different effects on the gut microbiota and disease progression in an Alzheimer's disease rat model
    Park, Sunmin
    Zhang, Ting
    Wu, Xuangao
    Qiu, Jing Yi
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2020, 67 (02) : 188 - 198
  • [55] A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer's Disease
    Pawlosky, Robert J.
    Kashiwaya, Yoshihero
    King, M. Todd
    Veech, Richard L.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [56] Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease
    Pawlosky, Robert J.
    Kemper, Martin F.
    Kashiwaya, Yoshihero
    King, Michael Todd
    Mattson, Mark P.
    Veech, Richard L.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2017, 141 (02) : 195 - 207
  • [57] Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease
    Phillips, Matthew C. L.
    Deprez, Laura M.
    Mortimer, Grace M. N.
    Murtagh, Deborah K. J.
    McCoy, Stacey
    Mylchreest, Ruth
    Gilbertson, Linda J.
    Clark, Karen M.
    Simpson, Patricia, V
    McManus, Eileen J.
    Oh, Jee-Eun
    Yadavaraj, Satish
    King, Vanessa M.
    Pillai, Avinesh
    Romero-Ferrando, Beatriz
    Brinkhuis, Martijn
    Copeland, Bronwyn M.
    Samad, Shah
    Liao, Shenyang
    Schepel, Jan A. C.
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [58] ESTIMATION OF METABOLITE CONCENTRATIONS FROM LOCALIZED IN-VIVO PROTON NMR-SPECTRA
    PROVENCHER, SW
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1993, 30 (06) : 672 - 679
  • [59] Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease
    Pulliam, Lynn
    Sun, Bing
    Mustapic, Maja
    Chawla, Sahil
    Kapogiannis, Dimitrios
    [J]. JOURNAL OF NEUROVIROLOGY, 2019, 25 (05) : 702 - 709
  • [60] The metabolic syndrome and Alzheimer disease
    Razay, George
    Vreugdenhil, Anthea
    Wilcock, Gordon
    [J]. ARCHIVES OF NEUROLOGY, 2007, 64 (01) : 93 - 96